A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris
Del Rosso, J.Q.; Schmidt, N.F.
Cutis 85(1): 15-24
2010
ISSN/ISBN: 0011-4162 PMID: 20184207 Document Number: 639552
This article reviews anti-inflammatory properties of clindamycin, which is often used topically for the management of acne vulgaris, usually in combination with other agents. The efficacy of clindamycin in acne treatment has been shown to be sustained for more than 3 decades. It is likely that anti-inflammatory effects play an important role in the therapeutic activity of topical clindamycin.
Document emailed within 1 workday
Related Documents
Onumah, N. 2013: A novel anti-inflammatory in treatment of acne vulgaris: the pseudopterosins Journal of Drugs in Dermatology: Jdd 12(10): 1177-1179Gold, M.H.; Rao, J.; Goldman, M.P.; Bridges, T.M.; Bradshaw, V.L.; Boring, M.M.; Guider, A.N. 2005: A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution Journal of Drugs in Dermatology: Jdd 4(1): 64-70
Bowman, S.; Gold, M.; Nasir, A.; Vamvakias, G. 2005: Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study Journal of Drugs in Dermatology: Jdd 4(5): 611-618
Tanghetti, E.; Dhawan, S.; Green, L.; Ling, M.; Downie, J.; Germain, M.A.; Kasteler, J.S.; Kircik, L.; Oefelein, M.G.; Draelos, Z. 2011: Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris Journal of Drugs in Dermatology: Jdd 10(7): 783-792
Tschen, E.; Jones, T. 2002: A new treatment for acne vulgaris combining benzoyl peroxide with clindamycin Journal of Drugs in Dermatology: Jdd 1(2): 153-157
Stoughton, R.B.; Cornell, R.C.; Gange, R.W.; Walter, J.F. 1980: Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris Cutis 26(4): 424-425; 429
Zeichner, J.A.; Wong, V.; Linkner, R.V.; Haddican, M. 2013: Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris Journal of Drugs in Dermatology: Jdd 12(3): 277-282
Amar, L.; Kircik, L.H. 2018: Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel Journal of Drugs in Dermatology: Jdd 17(10): 1107-1112
Cook-Bolden, F.E. 2012: Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel Journal of Drugs in Dermatology: Jdd 11(4): 455-459
Kircik, L.H.; Dahl, A.; Yatskayer, M.; Raab, S.; Oresajo, C. 2012: Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris Journal of Drugs in Dermatology: Jdd 11(6): 737-740
Cunliffe, W.J.; Cotterill, J.A. 1973: Clindamycin as an alternative to tetracycline in severe acne vulgaris Practitioner 210(259): 698-700
Thiboutot, D. 2008: Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris Journal of Drugs in Dermatology: Jdd 7(1): 13-16
Tanghetti, E.; Abramovits, W.; Solomon, B.; Loven, K.; Shalita, A. 2006: Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial Journal of Drugs in Dermatology: Jdd 5(3): 256-261
Eichenfield, L.F.; Alió Sáenz, A.B. 2011: Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study Journal of Drugs in Dermatology: Jdd 10(12): 1382-1396
Dhawan, S.S. 2009: Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris Cutis 83(5): 265-272
Del Rosso, J.Q. 2007: Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris Journal of Drugs in Dermatology: Jdd 6(6): 616-622
Jain, V.K.; Chopra, K.L.; Dayal, S. 1998: Comparative evaluation of topical benzoyl peroxide, metronidazole and benzoyl peroxide - clindamycin combination in treatment of acne vulgaris Indian Journal of Dermatology Venereology and Leprology 64(2): 71-74
Jurairattanaporn, N.; Chalermchai, T.; Ophaswongse, S.; Udompataikul, M. 2017: Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris Journal of the Medical Association of Thailand 100(1): 78-85
Riddle, C.C.; Terrell, S.N.; Menser, M.B.; Aires, D.J.; Schweiger, E.S. 2009: A review of photodynamic therapy (PDT) for the treatment of acne vulgaris Journal of Drugs in Dermatology: Jdd 8(11): 1010-1019
Ortiz, A.; Van Vliet, M.; Lask, G.P.; Yamauchi, P.S. 2005: A review of lasers and light sources in the treatment of acne vulgaris Journal of Cosmetic and Laser Therapy 7(2): 69-75